Clinical Trial Update: A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two doses of autologous H-MSC plus biomaterial against iliac crest autograft for bone healing in nonunion fractures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonunion Fracture

Drugs mentioned

• BM Autologous H-MSC+Biomaterial
• Iliac crest autograft (autograft bone graft)

Snippet

Sponsor: Universidad Autonoma de Madrid | Conditions: Non Union Fracture | Phase 3 | Status: COMPLETED